Suzuken Co Ltd
TSE:9987
Relative Value
The Relative Value of one Suzuken Co Ltd stock under the Base Case scenario is 6 243.22 JPY. Compared to the current market price of 3 525 JPY, Suzuken Co Ltd is Undervalued by 44%.
Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.
Multiples Across Competitors
Competitors Multiples
Suzuken Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
JP |
S
|
Suzuken Co Ltd
TSE:9987
|
292B JPY | 0.1 | 15.1 | 1 | 1.3 | |
US |
![]() |
Mckesson Corp
NYSE:MCK
|
52.3B USD | 0.2 | 14.7 | 10.1 | 11.5 | |
US |
![]() |
Amerisourcebergen Corp
NYSE:ABC
|
33.6B USD | 0.1 | 20.8 | 10.9 | 14.1 | |
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
20.7B USD | 0.1 | 44.8 | 9.1 | 12.9 | |
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
84.8B CNY | 0.4 | 14.4 | 11.1 | 11.1 | |
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
78.2B HKD | 0.1 | 8.3 | 1.1 | 1.4 | |
CN |
H
|
Huadong Medicine Co Ltd
SZSE:000963
|
69.1B CNY | 1.8 | 27.1 | 20.6 | 20.6 | |
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD | 0.8 | 20.3 | 10.4 | 12.9 | |
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
11.8T KRW | 5.7 | 75.1 | 48.6 | 49.8 | |
IT |
![]() |
Amplifon SpA
MIL:AMP
|
7.4B EUR | 3.5 | 41.4 | 15.9 | 29.1 | |
DE |
![]() |
McKesson Europe AG
XHAM:CLS1
|
4.9B EUR | 0.2 | -5 | 3.7 | 17.6 |
P/S Multiple | Revenue Growth | |||
---|---|---|---|---|
JP |
S
|
Suzuken Co Ltd
TSE:9987
|
0.1
|
6%
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
0.2
|
17%
|
US |
![]() |
Amerisourcebergen Corp
NYSE:ABC
|
0.1
|
19%
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
0.1
|
27%
|
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
0.4
|
38%
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
0.1
|
38%
|
CN |
H
|
Huadong Medicine Co Ltd
SZSE:000963
|
1.8
|
42%
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
0.8
|
13%
|
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
5.7
|
69%
|
IT |
![]() |
Amplifon SpA
MIL:AMP
|
3.5
|
24%
|
DE |
![]() |
McKesson Europe AG
XHAM:CLS1
|
0.2
|
N/A |
P/E Multiple | Earnings Growth | |||
---|---|---|---|---|
JP |
S
|
Suzuken Co Ltd
TSE:9987
|
15.1
|
56%
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
14.7
|
28%
|
US |
![]() |
Amerisourcebergen Corp
NYSE:ABC
|
20.8
|
65%
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
44.8
|
N/A |
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
14.4
|
42%
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
8.3
|
37%
|
CN |
H
|
Huadong Medicine Co Ltd
SZSE:000963
|
27.1
|
87%
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
20.3
|
57%
|
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
75.1
|
198%
|
IT |
![]() |
Amplifon SpA
MIL:AMP
|
41.4
|
52%
|
DE |
![]() |
McKesson Europe AG
XHAM:CLS1
|
Negative Multiple: -5 | N/A |
EV/EBITDA Multiple | EBITDA Growth | |||
---|---|---|---|---|
JP |
S
|
Suzuken Co Ltd
TSE:9987
|
1
|
39%
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
10.1
|
14%
|
US |
![]() |
Amerisourcebergen Corp
NYSE:ABC
|
10.9
|
24%
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
9.1
|
29%
|
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
11.1
|
91%
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
1.1
|
22%
|
CN |
H
|
Huadong Medicine Co Ltd
SZSE:000963
|
20.6
|
101%
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
10.4
|
21%
|
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
48.6
|
142%
|
IT |
![]() |
Amplifon SpA
MIL:AMP
|
15.9
|
25%
|
DE |
![]() |
McKesson Europe AG
XHAM:CLS1
|
3.7
|
N/A |
EV/EBIT Multiple | EBIT Growth | |||
---|---|---|---|---|
JP |
S
|
Suzuken Co Ltd
TSE:9987
|
1.3
|
-83%
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
11.5
|
22%
|
US |
![]() |
Amerisourcebergen Corp
NYSE:ABC
|
14.1
|
32%
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
12.9
|
48%
|
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
11.1
|
69%
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
1.4
|
29%
|
CN |
H
|
Huadong Medicine Co Ltd
SZSE:000963
|
20.6
|
73%
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
12.9
|
30%
|
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
49.8
|
141%
|
IT |
![]() |
Amplifon SpA
MIL:AMP
|
29.1
|
46%
|
DE |
![]() |
McKesson Europe AG
XHAM:CLS1
|
17.6
|
N/A |